Mourão Maria Vitória Assumpção, Toledo Antonio, Gomes Luciana Inácia, Freire Verônica Vieira, Rabello Ana
Hospital Infantil João Paulo II, Fundação Hospitalar do Estado de Minas Gerais, Belo Horizonte, MG, Brasil.
Serviço Multiprofissional de Infectologia, Universidade José do Rosário Vellano-UNIFENAS, Belo Horizonte, MG, Brasil.
Mem Inst Oswaldo Cruz. 2014 Apr;109(2):147-53. doi: 10.1590/0074-0276140257. Epub 2014 Mar 4.
Clinical and laboratory risk factors for death from visceral leishmaniasis (VL) are relatively known, but quantitative real-time polymerase chain reaction (qPCR) might assess the role of parasite load in determining clinical outcome. The aim of this study was to identify risk factors, including parasite load in peripheral blood, for VL poor outcome among children. This prospective cohort study evaluated children aged ≤ 12 years old with VL diagnosis at three times: pre-treatment (T0), during treatment (T1) and post-treatment (T2). Forty-eight patients were included and 16 (33.3%) met the criteria for poor outcome. Age ≤ 12 months [relative risk (RR) 3.51; 95% confidence interval (CI) 1.89-6.52], tachydyspnoea (RR 3.46; 95% CI 2.19-5.47), bacterial infection (RR 3.08; 95% CI 1.27-7.48), liver enlargement (RR 3.00; 95% CI 1.44-6.23) and low serum albumin (RR 7.00; 95% CI 1.80-27.24) were identified as risk factors. qPCR was positive in all patients at T0 and the parasite DNA was undetectable in 76.1% of them at T1 and in 90.7% at T2. There was no statistical association between parasite load at T0 and poor outcome.
内脏利什曼病(VL)死亡的临床和实验室风险因素已为人熟知,但定量实时聚合酶链反应(qPCR)或许可评估寄生虫负荷在决定临床结局中的作用。本研究旨在确定儿童VL预后不良的风险因素,包括外周血中的寄生虫负荷。这项前瞻性队列研究对年龄≤12岁的VL诊断儿童在三个时间点进行了评估:治疗前(T0)、治疗期间(T1)和治疗后(T2)。纳入了48例患者,其中16例(33.3%)符合预后不良标准。年龄≤12个月[相对危险度(RR)3.51;95%置信区间(CI)1.89 - 6.52]、呼吸急促(RR 3.46;95% CI 2.19 - 5.47)、细菌感染(RR 3.08;95% CI 1.27 - 7.48)、肝脏肿大(RR 3.00;95% CI 1.44 - 6.23)和低血清白蛋白(RR 7.00;95% CI 1.80 - 27.24)被确定为风险因素。所有患者在T0时qPCR均为阳性,76.1%的患者在T1时寄生虫DNA检测不到,在T2时为90.7%。T0时的寄生虫负荷与预后不良之间无统计学关联。